Literature DB >> 33669775

Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer.

Rhynelle S Dmello1, Sarah Q To1, Ashwini L Chand1.   

Abstract

Liver metastasis is the primary contributor to the death of patients with colorectal cancer. Despite the overall success of current treatments including targeted therapy, chemotherapy, and immunotherapy combinations in colorectal cancer patients, the prognosis of patients with liver metastasis remains poor. Recent studies have highlighted the importance of the tumour microenvironment and the crosstalk within that determines the fate of circulating tumour cells in distant organs. Understanding the interactions between liver resident cells and tumour cells colonising the liver opens new therapeutic windows for the successful treatment of metastatic colorectal cancer. Here we discuss critical cellular interactions within the tumour microenvironment in primary tumours and in liver metastases that highlight potential therapeutic targets. We also discuss recent therapeutic advances for the treatment of metastatic colorectal cancer.

Entities:  

Keywords:  cytokines; immunotherapy; inflammation; metastatic colorectal cancer; targeted therapy; tumour heterogeneity; tumour microenvironment

Mesh:

Year:  2021        PMID: 33669775      PMCID: PMC7922123          DOI: 10.3390/ijms22042067

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  110 in total

1.  When less is more: maintenance therapy in colorectal cancer.

Authors:  Joleen M Hubbard; Axel Grothey
Journal:  Lancet       Date:  2015-04-07       Impact factor: 79.321

2.  Global patterns and trends in colorectal cancer incidence in young adults.

Authors:  Rebecca L Siegel; Lindsey A Torre; Isabelle Soerjomataram; Richard B Hayes; Freddie Bray; Thomas K Weber; Ahmedin Jemal
Journal:  Gut       Date:  2019-09-05       Impact factor: 23.059

3.  Endothelial cell-derived fibronectin extra domain A promotes colorectal cancer metastasis via inducing epithelial-mesenchymal transition.

Authors:  Juanjuan Ou; Yuan Peng; Jia Deng; Hongming Miao; Jie Zhou; Lin Zha; Rongbin Zhou; Liqing Yu; Hang Shi; Houjie Liang
Journal:  Carcinogenesis       Date:  2014-04-17       Impact factor: 4.944

4.  Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.

Authors:  Eric Van Cutsem; Josep Tabernero; Radek Lakomy; Hans Prenen; Jana Prausová; Teresa Macarulla; Paul Ruff; Guy A van Hazel; Vladimir Moiseyenko; David Ferry; Joe McKendrick; Jonathan Polikoff; Alexia Tellier; Rémi Castan; Carmen Allegra
Journal:  J Clin Oncol       Date:  2012-09-04       Impact factor: 44.544

5.  MIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis.

Authors:  Chun-Ting Hu; Li-Li Guo; Na Feng; Lei Zhang; Na Zhou; Li-Li Ma; Lan Shen; Gui-Hui Tong; Qian-Wen Yan; Shi-Jie Zhu; Xiu-Wu Bian; Mao D Lai; Yong-Jian Deng; Yan-Qing Ding
Journal:  Oncotarget       Date:  2015-09-08

6.  Hepatocytes direct the formation of a pro-metastatic niche in the liver.

Authors:  Jae W Lee; Meredith L Stone; Paige M Porrett; Stacy K Thomas; Chad A Komar; Joey H Li; Devora Delman; Kathleen Graham; Whitney L Gladney; Xia Hua; Taylor A Black; Austin L Chien; Krishna S Majmundar; Jeffrey C Thompson; Stephanie S Yee; Mark H O'Hara; Charu Aggarwal; Dong Xin; Abraham Shaked; Mingming Gao; Dexi Liu; Mitesh J Borad; Ramesh K Ramanathan; Erica L Carpenter; Ailing Ji; Maria C de Beer; Frederick C de Beer; Nancy R Webb; Gregory L Beatty
Journal:  Nature       Date:  2019-03-06       Impact factor: 49.962

Review 7.  Engineered models to parse apart the metastatic cascade.

Authors:  Lauren A Hapach; Jenna A Mosier; Wenjun Wang; Cynthia A Reinhart-King
Journal:  NPJ Precis Oncol       Date:  2019-08-21

8.  Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition.

Authors:  Jennie Engstrand; Cecilia Strömberg; Henrik Nilsson; Jacob Freedman; Eduard Jonas
Journal:  World J Surg Oncol       Date:  2019-12-26       Impact factor: 2.754

9.  The cytokine secretion profile of mesenchymal stromal cells is determined by surface structure of the microenvironment.

Authors:  Daniëlle G Leuning; Nick R M Beijer; Nadia A du Fossé; Steven Vermeulen; Ellen Lievers; Cees van Kooten; Ton J Rabelink; Jan de Boer
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

10.  The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.

Authors:  Camille Maringe; James Spicer; Melanie Morris; Arnie Purushotham; Ellen Nolte; Richard Sullivan; Bernard Rachet; Ajay Aggarwal
Journal:  Lancet Oncol       Date:  2020-07-20       Impact factor: 54.433

View more
  8 in total

1.  Partial response of donafenib as the third-line therapy in metastatic colon cancer: A case report.

Authors:  Yang Yang; Hong Zhu; Qiu Li
Journal:  Medicine (Baltimore)       Date:  2021-09-17       Impact factor: 1.889

2.  Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer.

Authors:  Nami Sato; Nozomu Sakai; Katsunori Furukawa; Tsukasa Takayashiki; Satoshi Kuboki; Shigetsugu Takano; Gaku Ohira; Hisahiro Matsubara; Masayuki Ohtsuka
Journal:  Oncol Rep       Date:  2022-03-10       Impact factor: 3.906

3.  High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy.

Authors:  Friederike Wrana; Katharina Dötzer; Martin Prüfer; Jens Werner; Barbara Mayer
Journal:  Cancers (Basel)       Date:  2022-04-12       Impact factor: 6.575

4.  Identification of a Prognostic Transcriptome Signature for Hepatocellular Carcinoma with Lymph Node Metastasis.

Authors:  Jie Ma; Xue-Qin Chen; Zuo-Lin Xiang
Journal:  Oxid Med Cell Longev       Date:  2022-07-06       Impact factor: 7.310

Review 5.  New Drug Development and Clinical Trial Design by Applying Genomic Information Management.

Authors:  Young Kyung Ko; Jeong-An Gim
Journal:  Pharmaceutics       Date:  2022-07-24       Impact factor: 6.525

Review 6.  Which patients are prone to suffer liver metastasis? A review of risk factors of metachronous liver metastasis of colorectal cancer.

Authors:  Mengdi Hao; Kun Wang; Yuhan Ding; Huimin Li; Yin Liu; Lei Ding
Journal:  Eur J Med Res       Date:  2022-07-25       Impact factor: 4.981

Review 7.  Impact of One-Carbon Metabolism-Driving Epitranscriptome as a Therapeutic Target for Gastrointestinal Cancer.

Authors:  Yu Takeda; Ryota Chijimatsu; Andrea Vecchione; Takahiro Arai; Toru Kitagawa; Ken Ofusa; Masami Yabumoto; Takaaki Hirotsu; Hidetoshi Eguchi; Yuichiro Doki; Hideshi Ishii
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

Review 8.  STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential.

Authors:  Sarah Q To; Rhynelle S Dmello; Anna K Richards; Matthias Ernst; Ashwini L Chand
Journal:  Cancers (Basel)       Date:  2022-01-15       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.